Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.
P/B ratio for Shin Poong Pharm.Co.,Ltd. (019170.KS)
P/B ratio as of 2023: 2.62
According to Shin Poong Pharm.Co.,Ltd.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.62. At the end of 2022 the company had a P/B ratio of 3.19.
P/B ratio history for Shin Poong Pharm.Co.,Ltd. from 2007 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 2.62 |
| 2022 | 3.19 |
| 2021 | 4.63 |
| 2020 | 16.71 |
| 2019 | 1.74 |
| 2018 | 1.52 |
| 2017 | 1.88 |
| 2016 | 1.33 |
| 2015 | 0.76 |
| 2014 | 0.92 |
| 2013 | 0.93 |
| 2012 | 1.06 |
| 2011 | 0.92 |
| 2010 | 0.75 |
| 2009 | 0.64 |
| 2008 | 0.52 |
| 2007 | 0.80 |